Ovis aries strain OAR_USU_Benz2616 breed Rambouillet chromosome 23, ARS-UI_Ramb_v2.0, whole genome shotgun sequence.
Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia; Eutheria; Laurasiatheria; Artiodactyla; Ruminantia; Pecora; Bovidae; Caprinae; Ovis.
REFSEQ INFORMATION: The reference sequence is identical to\nCM028726.1.\nAssembly name: ARS-UI_Ramb_v2.0\nThe genomic sequence for this RefSeq record is from the\nwhole-genome assembly released by the University of Idaho on\n2021/02/03. The original whole-genome shotgun project has the\naccession JAEVFA000000000.1.\n\n##Genome-Assembly-Data-START##\nAssembly Provider :: University of Idaho\nAssembly Date :: NOV-2020\nAssembly Method :: Canu v. 1.8; Nanopolish v. 0.12.5; Salsa\n v. 2.2; PB Jelly v. 15.8.24; Freebayes v.\n 1.3.1\nAssembly Name :: ARS-UI_Ramb_v2.0\nGenome Representation :: Full\nExpected Final Version :: Yes\nGenome Coverage :: 55.0x\nSequencing Technology :: Oxford Nanopore PromethION; PacBio RSII;\n Illumina HiSeq\n##Genome-Assembly-Data-END##\n\n##Genome-Annotation-Data-START##\nAnnotation Provider :: NCBI\nAnnotation Status :: Full annotation\nAnnotation Name :: Ovis aries Annotation Release 104\nAnnotation Version :: 104\nAnnotation Pipeline :: NCBI eukaryotic genome annotation\n pipeline\nAnnotation Software Version :: 9.0\nAnnotation Method :: Best-placed RefSeq; Gnomon\nFeatures Annotated :: Gene; mRNA; CDS; ncRNA\n##Genome-Annotation-Data-END##
Derived by automated computational analysis using gene prediction method: Gnomon.
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins
uncharacterized LOC105613831, transcript variant X1
COORDINATES: polyA evidence [ECO:0006239]
uncharacterized LOC105613831, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 25% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 35 Proteins
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 61 Proteins
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 63 Proteins
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 11% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 12% coverage of the annotated genomic feature by RNAseq alignments
COORDINATES: cap analysis [ECO:0007248] and polyA evidence [ECO:0006239]
par-6 family cell polarity regulator gamma
activity-dependent neuroprotector homeobox protein 2
ribosome binding factor A, transcript variant X1
ribosome binding factor A, transcript variant X2
putative ribosome-binding factor A, mitochondrial isoform X1
putative ribosome-binding factor A, mitochondrial isoform X2
uncharacterized LOC121817713, transcript variant X1
uncharacterized LOC121817713, transcript variant X2
probable 2-ketogluconate reductase, transcript variant X3
probable 2-ketogluconate reductase, transcript variant X2
probable 2-ketogluconate reductase, transcript variant X4
probable 2-ketogluconate reductase, transcript variant X1
thioredoxin like 4A, transcript variant X2
thioredoxin like 4A, transcript variant X1
thioredoxin like 4A, transcript variant X3
thioredoxin like 4A, transcript variant X4
heat shock factor binding protein 1 like 1, transcript variant X2
heat shock factor-binding protein 1-like protein 1 isoform X2
heat shock factor binding protein 1 like 1, transcript variant X5
heat shock factor binding protein 1 like 1, transcript variant X4
heat shock factor binding protein 1 like 1, transcript variant X3
heat shock factor binding protein 1 like 1, transcript variant X1
heat shock factor-binding protein 1-like protein 1 isoform X4
heat shock factor-binding protein 1-like protein 1 isoform X3
heat shock factor-binding protein 1-like protein 1 isoform X1
solute carrier family 66 member 2; Derived by automated computational analysis using gene prediction method: BestRefSeq,Gnomon.
solute carrier family 66 member 2, transcript variant X1
solute carrier family 66 member 2, transcript variant X2
similar to RNA sequence, mRNA (same species):RefSeq:NM_001126356.1
annotated by transcript or proteomic data
The RefSeq transcript has 1 substitution compared to this genomic sequence; Derived by automated computational analysis using gene prediction method: BestRefSeq.
solute carrier family 66 member 2 isoform X1
similar to AA sequence (same species):RefSeq:NP_001119828.1
The RefSeq protein has 1 substitution compared to this genomic sequence; Derived by automated computational analysis using gene prediction method: BestRefSeq.
solute carrier family 66 member 2 isoform X2
potassium voltage-gated channel modifier subfamily G member 2
potassium voltage-gated channel subfamily G member 2
CTD phosphatase subunit 1, transcript variant X3
CTD phosphatase subunit 1, transcript variant X4
CTD phosphatase subunit 1, transcript variant X1
CTD phosphatase subunit 1, transcript variant X2
RNA polymerase II subunit A C-terminal domain phosphatase isoform X1
RNA polymerase II subunit A C-terminal domain phosphatase isoform X2
RNA polymerase II subunit A C-terminal domain phosphatase isoform X3
nuclear factor of activated T cells 1, transcript variant X3
nuclear factor of activated T cells 1, transcript variant X7
nuclear factor of activated T cells 1, transcript variant X6
nuclear factor of activated T cells 1, transcript variant X5
nuclear factor of activated T-cells, cytoplasmic 1 isoform X3
nuclear factor of activated T-cells, cytoplasmic 1 isoform X6
nuclear factor of activated T-cells, cytoplasmic 1 isoform X5
nuclear factor of activated T-cells, cytoplasmic 1 isoform X7
nuclear factor of activated T cells 1, transcript variant X1
nuclear factor of activated T cells 1, transcript variant X2
nuclear factor of activated T-cells, cytoplasmic 1 isoform X1
nuclear factor of activated T-cells, cytoplasmic 1 isoform X2
nuclear factor of activated T cells 1, transcript variant X4
nuclear factor of activated T-cells, cytoplasmic 1 isoform X4
nuclear factor of activated T cells 1, transcript variant X8
nuclear factor of activated T-cells, cytoplasmic 1 isoform X8
ATPase phospholipid transporting 9B (putative), transcript variant X6
ATPase phospholipid transporting 9B (putative), transcript variant X4
ATPase phospholipid transporting 9B (putative), transcript variant X3
ATPase phospholipid transporting 9B (putative), transcript variant X5
ATPase phospholipid transporting 9B (putative), transcript variant X2
ATPase phospholipid transporting 9B (putative), transcript variant X1
probable phospholipid-transporting ATPase IIB isoform X6
probable phospholipid-transporting ATPase IIB isoform X4
probable phospholipid-transporting ATPase IIB isoform X3
probable phospholipid-transporting ATPase IIB isoform X5
probable phospholipid-transporting ATPase IIB isoform X2
probable phospholipid-transporting ATPase IIB isoform X1
Derived by automated computational analysis using gene prediction method: cmsearch.
COORDINATES: nucleotide motif:Rfam:12.0:RF00026
Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
transfer RNA cysteine (anticodon GCA); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
COORDINATES: nucleotide motif:Rfam:12.0:RF00004
myelin basic protein, transcript variant X3
myelin basic protein, transcript variant X1
myelin basic protein, transcript variant X2
myelin basic protein, transcript variant X4
zinc finger protein 236, transcript variant X1
zinc finger protein 236, transcript variant X3
zinc finger protein 236, transcript variant X2
zinc finger protein 236, transcript variant X4
zinc finger protein 236, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 EST, 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 52 samples with support for all annotated introns
uncharacterized LOC105604382, transcript variant X2
uncharacterized LOC105604382, transcript variant X1
COORDINATES: nucleotide motif:Rfam:12.0:RF00156
collagen alpha-1(I) chain-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
collagen alpha-1(I) chain-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 long SRA reads, and 97% coverage of the annotated genomic feature by RNAseq alignments, including 25 samples with support for all annotated introns
zinc finger protein 516, transcript variant X1
zinc finger protein 516, transcript variant X7
zinc finger protein 516, transcript variant X3
zinc finger protein 516, transcript variant X4
zinc finger protein 516, transcript variant X2
zinc finger protein 516, transcript variant X5
zinc finger protein 516, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 88% coverage of the annotated genomic feature by RNAseq alignments
zinc binding alcohol dehydrogenase domain containing 2
zinc finger protein 407, transcript variant X1
zinc finger protein 407, transcript variant X2
zinc finger protein 407, transcript variant X3
carnosine dipeptidase 1, transcript variant X4
carnosine dipeptidase 1, transcript variant X3
carnosine dipeptidase 1, transcript variant X2
carnosine dipeptidase 1, transcript variant X1
uncharacterized LOC105604388, transcript variant X2
uncharacterized LOC105604388, transcript variant X3
uncharacterized LOC105604388, transcript variant X1
uncharacterized LOC105604388, transcript variant X4
carnosine dipeptidase 2, transcript variant X1
carnosine dipeptidase 2, transcript variant X4
carnosine dipeptidase 2, transcript variant X2
carnosine dipeptidase 2, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 66% coverage of the annotated genomic feature by RNAseq alignments
uncharacterized protein C18orf63 homolog
cytochrome b5 type A (microsomal); Derived by automated computational analysis using gene prediction method: BestRefSeq.
Derived by automated computational analysis using gene prediction method: BestRefSeq.
translocase of inner mitochondrial membrane 21
mitochondrial import inner membrane translocase subunit Tim21
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 85% coverage of the annotated genomic feature by RNAseq alignments
transfer RNA alanine (anticodon CGC); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
transfer RNA phenylalanine (anticodon GAA); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
neuropilin and tolloid like 1, transcript variant X1
neuropilin and tolloid like 1, transcript variant X2
neuropilin and tolloid like 1, transcript variant X3
neuropilin and tolloid like 1, transcript variant X4
neuropilin and tolloid-like protein 1 isoform X1
neuropilin and tolloid-like protein 1 isoform X2
neuropilin and tolloid-like protein 1 isoform X3
fibrinogen silencer-binding protein-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
transfer RNA cysteine (anticodon ACA); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
suppressor of cytokine signaling 6, transcript variant X2
suppressor of cytokine signaling 6, transcript variant X1
coiled-coil domain containing 102B, transcript variant X1
coiled-coil domain containing 102B, transcript variant X2
coiled-coil domain-containing protein 102B isoform X1
coiled-coil domain containing 102B, transcript variant X3
coiled-coil domain-containing protein 102B isoform X2
thioredoxin related transmembrane protein 3
dermatan sulfate epimerase like, transcript variant X2
dermatan sulfate epimerase like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 17 Proteins
transfer RNA glycine (anticodon CCC); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
transfer RNA lysine (anticodon UUU); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
pyrin domain-containing protein 3-like, transcript variant X2
pyrin domain-containing protein 3-like, transcript variant X1
pyrin domain-containing protein 3-like isoform X1
uncharacterized protein LOC121817730 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 17 Proteins, and 91% coverage of the annotated genomic feature by RNAseq alignments
phosphatidylinositol 3-kinase catalytic subunit type 3, transcript variant X3
phosphatidylinositol 3-kinase catalytic subunit type 3, transcript variant X1
phosphatidylinositol 3-kinase catalytic subunit type 3 isoform X3
phosphatidylinositol 3-kinase catalytic subunit type 3 isoform X1
phosphatidylinositol 3-kinase catalytic subunit type 3, transcript variant X5
phosphatidylinositol 3-kinase catalytic subunit type 3, transcript variant X6
phosphatidylinositol 3-kinase catalytic subunit type 3, transcript variant X2
phosphatidylinositol 3-kinase catalytic subunit type 3 isoform X2
phosphatidylinositol 3-kinase catalytic subunit type 3, transcript variant X4
phosphatidylinositol 3-kinase catalytic subunit type 3 isoform X4
transfer RNA tryptophan (anticodon CCA); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 21 Proteins, and 18% coverage of the annotated genomic feature by RNAseq alignments
peptidyl-prolyl cis-trans isomerase A-like
uncharacterized LOC121817765, transcript variant X2
uncharacterized LOC121817765, transcript variant X3
uncharacterized LOC121817765, transcript variant X1
CUGBP Elav-like family member 4, transcript variant X44
CUGBP Elav-like family member 4, transcript variant X45
CUGBP Elav-like family member 4, transcript variant X47
CUGBP Elav-like family member 4, transcript variant X48
CUGBP Elav-like family member 4, transcript variant X49
CUGBP Elav-like family member 4, transcript variant X1
CUGBP Elav-like family member 4, transcript variant X42
CUGBP Elav-like family member 4, transcript variant X12
CUGBP Elav-like family member 4, transcript variant X27
CUGBP Elav-like family member 4, transcript variant X3
CUGBP Elav-like family member 4, transcript variant X14
CUGBP Elav-like family member 4, transcript variant X29
CUGBP Elav-like family member 4, transcript variant X4
CUGBP Elav-like family member 4, transcript variant X15
CUGBP Elav-like family member 4, transcript variant X30
CUGBP Elav-like family member 4, transcript variant X6
CUGBP Elav-like family member 4, transcript variant X18
CUGBP Elav-like family member 4, transcript variant X33
CUGBP Elav-like family member 4, transcript variant X2
CUGBP Elav-like family member 4, transcript variant X43
CUGBP Elav-like family member 4, transcript variant X13
CUGBP Elav-like family member 4, transcript variant X28
CUGBP Elav-like family member 4, transcript variant X5
CUGBP Elav-like family member 4, transcript variant X16
CUGBP Elav-like family member 4, transcript variant X31
CUGBP Elav-like family member 4, transcript variant X17
CUGBP Elav-like family member 4, transcript variant X32
CUGBP Elav-like family member 4, transcript variant X19
CUGBP Elav-like family member 4, transcript variant X34
CUGBP Elav-like family member 4, transcript variant X7
CUGBP Elav-like family member 4, transcript variant X26
CUGBP Elav-like family member 4, transcript variant X35
CUGBP Elav-like family member 4, transcript variant X21
CUGBP Elav-like family member 4, transcript variant X37
CUGBP Elav-like family member 4, transcript variant X50
CUGBP Elav-like family member 4, transcript variant X38
CUGBP Elav-like family member 4, transcript variant X9
CUGBP Elav-like family member 4, transcript variant X24
CUGBP Elav-like family member 4, transcript variant X41
CUGBP Elav-like family member 4, transcript variant X8
CUGBP Elav-like family member 4, transcript variant X46
CUGBP Elav-like family member 4, transcript variant X20
CUGBP Elav-like family member 4, transcript variant X36
CUGBP Elav-like family member 4, transcript variant X10
CUGBP Elav-like family member 4, transcript variant X22
CUGBP Elav-like family member 4, transcript variant X39
CUGBP Elav-like family member 4, transcript variant X23
CUGBP Elav-like family member 4, transcript variant X40
CUGBP Elav-like family member 4, transcript variant X11
CUGBP Elav-like family member 4, transcript variant X25
CUGBP Elav-like family member 4 isoform X44
CUGBP Elav-like family member 4 isoform X45
CUGBP Elav-like family member 4 isoform X47
CUGBP Elav-like family member 4 isoform X48
CUGBP Elav-like family member 4 isoform X49
CUGBP Elav-like family member 4 isoform X42
CUGBP Elav-like family member 4 isoform X43
CUGBP Elav-like family member 4 isoform X46
CUGBP Elav-like family member 4 isoform X1
CUGBP Elav-like family member 4 isoform X12
CUGBP Elav-like family member 4 isoform X27
CUGBP Elav-like family member 4 isoform X3
CUGBP Elav-like family member 4 isoform X14
CUGBP Elav-like family member 4 isoform X29
CUGBP Elav-like family member 4 isoform X4
CUGBP Elav-like family member 4 isoform X15
CUGBP Elav-like family member 4 isoform X30
CUGBP Elav-like family member 4 isoform X6
CUGBP Elav-like family member 4 isoform X18
CUGBP Elav-like family member 4 isoform X33
CUGBP Elav-like family member 4 isoform X2
CUGBP Elav-like family member 4 isoform X13
CUGBP Elav-like family member 4 isoform X28
CUGBP Elav-like family member 4 isoform X5
CUGBP Elav-like family member 4 isoform X16
CUGBP Elav-like family member 4 isoform X31
CUGBP Elav-like family member 4 isoform X17
CUGBP Elav-like family member 4 isoform X32
CUGBP Elav-like family member 4 isoform X19
CUGBP Elav-like family member 4 isoform X34
CUGBP Elav-like family member 4 isoform X7
CUGBP Elav-like family member 4 isoform X26
CUGBP Elav-like family member 4 isoform X35
CUGBP Elav-like family member 4 isoform X21
CUGBP Elav-like family member 4 isoform X37
CUGBP Elav-like family member 4 isoform X50
CUGBP Elav-like family member 4 isoform X38
CUGBP Elav-like family member 4 isoform X9
CUGBP Elav-like family member 4 isoform X24
CUGBP Elav-like family member 4 isoform X41
CUGBP Elav-like family member 4 isoform X8
CUGBP Elav-like family member 4 isoform X20
CUGBP Elav-like family member 4 isoform X36
CUGBP Elav-like family member 4 isoform X10
CUGBP Elav-like family member 4 isoform X22
CUGBP Elav-like family member 4 isoform X39
CUGBP Elav-like family member 4 isoform X23
CUGBP Elav-like family member 4 isoform X40
CUGBP Elav-like family member 4 isoform X11
CUGBP Elav-like family member 4 isoform X25
KIAA1328 ortholog, transcript variant X1
KIAA1328 ortholog, transcript variant X2
KIAA1328 ortholog, transcript variant X6
KIAA1328 ortholog, transcript variant X4
KIAA1328 ortholog, transcript variant X5
KIAA1328 ortholog, transcript variant X3
transfer RNA glutamic acid (anticodon CUC); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
tubulin polyglutamylase complex subunit 2, transcript variant X4
tubulin polyglutamylase complex subunit 2, transcript variant X3
tubulin polyglutamylase complex subunit 2, transcript variant X1
tubulin polyglutamylase complex subunit 2, transcript variant X2
tubulin polyglutamylase complex subunit 2 isoform X1
tubulin polyglutamylase complex subunit 2 isoform X2
tubulin polyglutamylase complex subunit 2 isoform X3
formin homology 2 domain containing 3, transcript variant X9
formin homology 2 domain containing 3, transcript variant X8
formin homology 2 domain containing 3, transcript variant X7
formin homology 2 domain containing 3, transcript variant X6
formin homology 2 domain containing 3, transcript variant X5
formin homology 2 domain containing 3, transcript variant X2
formin homology 2 domain containing 3, transcript variant X4
formin homology 2 domain containing 3, transcript variant X3
formin homology 2 domain containing 3, transcript variant X1
FH1/FH2 domain-containing protein 3 isoform X9
FH1/FH2 domain-containing protein 3 isoform X8
FH1/FH2 domain-containing protein 3 isoform X7
FH1/FH2 domain-containing protein 3 isoform X6
FH1/FH2 domain-containing protein 3 isoform X5
FH1/FH2 domain-containing protein 3 isoform X2
FH1/FH2 domain-containing protein 3 isoform X4
FH1/FH2 domain-containing protein 3 isoform X3
FH1/FH2 domain-containing protein 3 isoform X1
molybdenum cofactor sulfurase, transcript variant X2
molybdenum cofactor sulfurase, transcript variant X1
molybdenum cofactor sulfurase isoform X1
molybdenum cofactor sulfurase isoform X2
elongator acetyltransferase complex subunit 2, transcript variant X1
elongator acetyltransferase complex subunit 2, transcript variant X2
transfer RNA glutamic acid (anticodon UUC); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
regulation of nuclear pre-mRNA domain containing 1A, transcript variant X1
regulation of nuclear pre-mRNA domain containing 1A, transcript variant X2
regulation of nuclear pre-mRNA domain-containing protein 1A isoform X1
regulation of nuclear pre-mRNA domain-containing protein 1A isoform X2
polypeptide N-acetylgalactosaminyltransferase 1, transcript variant X5
polypeptide N-acetylgalactosaminyltransferase 1, transcript variant X4
polypeptide N-acetylgalactosaminyltransferase 1, transcript variant X1
polypeptide N-acetylgalactosaminyltransferase 1, transcript variant X2
polypeptide N-acetylgalactosaminyltransferase 1, transcript variant X3
polypeptide N-acetylgalactosaminyltransferase 1
INO80 complex subunit C, transcript variant X5
INO80 complex subunit C, transcript variant X1
INO80 complex subunit C, transcript variant X4
INO80 complex subunit C, transcript variant X3
INO80 complex subunit C, transcript variant X2
zinc finger protein 24, transcript variant X2
zinc finger protein 24, transcript variant X1
zinc finger and SCAN domain containing 30
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: substituted 1 base at 1 genomic stop codon; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: zinc finger and SCAN domain-containing protein 30
zinc finger protein 397, transcript variant X1
zinc finger protein 397, transcript variant X3
zinc finger protein 397, transcript variant X2
zinc finger protein 397, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 long SRA reads, and 94% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 40% coverage of the annotated genomic feature by RNAseq alignments
microtubule associated protein RP/EB family member 2, transcript variant X5
microtubule associated protein RP/EB family member 2, transcript variant X4
microtubule associated protein RP/EB family member 2, transcript variant X6
microtubule associated protein RP/EB family member 2, transcript variant X3
microtubule associated protein RP/EB family member 2, transcript variant X7
microtubule associated protein RP/EB family member 2, transcript variant X2
microtubule associated protein RP/EB family member 2, transcript variant X1
microtubule-associated protein RP/EB family member 2 isoform X3
microtubule-associated protein RP/EB family member 2 isoform X2
microtubule-associated protein RP/EB family member 2 isoform X1
microtubule-associated protein RP/EB family member 2 isoform X4
microtubule-associated protein RP/EB family member 2 isoform X5
dystrobrevin alpha, transcript variant X17
dystrobrevin alpha, transcript variant X9
dystrobrevin alpha, transcript variant X16
dystrobrevin alpha, transcript variant X13
dystrobrevin alpha, transcript variant X12
dystrobrevin alpha, transcript variant X7
dystrobrevin alpha, transcript variant X11
dystrobrevin alpha, transcript variant X10
dystrobrevin alpha, transcript variant X6
dystrobrevin alpha, transcript variant X15
dystrobrevin alpha, transcript variant X14
dystrobrevin alpha, transcript variant X8
dystrobrevin alpha, transcript variant X5
dystrobrevin alpha, transcript variant X1
dystrobrevin alpha, transcript variant X4
dystrobrevin alpha, transcript variant X3
dystrobrevin alpha, transcript variant X2
dystrobrevin alpha, transcript variant X21
dystrobrevin alpha, transcript variant X19
dystrobrevin alpha, transcript variant X18
dystrobrevin alpha, transcript variant X20
dystrobrevin alpha, transcript variant X23
dystrobrevin alpha, transcript variant X22
dystrobrevin alpha, transcript variant X24
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 77% coverage of the annotated genomic feature by RNAseq alignments
nucleolar protein 4, transcript variant X7
nucleolar protein 4, transcript variant X1
nucleolar protein 4, transcript variant X2
nucleolar protein 4, transcript variant X3
nucleolar protein 4, transcript variant X4
nucleolar protein 4, transcript variant X5
nucleolar protein 4, transcript variant X6
coiled-coil domain-containing protein 178
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 38% coverage of the annotated genomic feature by RNAseq alignments
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: deleted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: deleted 1 base in 1 codon; substituted 5 bases at 5 genomic stop codons; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: uncharacterized protein LOC121817702
GRB2 associated regulator of MAPK1 subtype 1, transcript variant X1
GRB2 associated regulator of MAPK1 subtype 1, transcript variant X2
GRB2-associated and regulator of MAPK protein 1 isoform X1
GRB2-associated and regulator of MAPK protein 1 isoform X2
meprin A subunit beta, transcript variant X8
meprin A subunit beta, transcript variant X2
meprin A subunit beta, transcript variant X4
meprin A subunit beta, transcript variant X7
meprin A subunit beta, transcript variant X6
meprin A subunit beta, transcript variant X3
meprin A subunit beta, transcript variant X5
meprin A subunit beta, transcript variant X1
meprin A subunit beta, transcript variant X9
ring finger protein 138, transcript variant X2
ring finger protein 138, transcript variant X1
E3 ubiquitin-protein ligase RNF138 isoform X2
E3 ubiquitin-protein ligase RNF138 isoform X1
trafficking protein particle complex subunit 8, transcript variant X1
trafficking protein particle complex subunit 8, transcript variant X2
trafficking protein particle complex subunit 8 isoform X1
trafficking protein particle complex subunit 8 isoform X2
trafficking protein particle complex subunit 8, transcript variant X3
trafficking protein particle complex subunit 8 isoform X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
transfer RNA glycine (anticodon ACC); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
beta-1,4-galactosyltransferase 6, transcript variant X1
beta-1,4-galactosyltransferase 6, transcript variant X4
beta-1,4-galactosyltransferase 6, transcript variant X3
beta-1,4-galactosyltransferase 6 isoform X1
beta-1,4-galactosyltransferase 6 isoform X4
beta-1,4-galactosyltransferase 6 isoform X3
beta-1,4-galactosyltransferase 6, transcript variant X2
beta-1,4-galactosyltransferase 6 isoform X2
beta-1,4-galactosyltransferase 6, transcript variant X5
beta-1,4-galactosyltransferase 6, transcript variant X6
beta-1,4-galactosyltransferase 6 isoform X5
transthyretin; Derived by automated computational analysis using gene prediction method: BestRefSeq.
similar to RNA sequence, mRNA (same species):RefSeq:NM_001009800.1
The RefSeq transcript has 5 substitutions compared to this genomic sequence; Derived by automated computational analysis using gene prediction method: BestRefSeq.
COORDINATES: ab initio prediction:SignalP:4.0
4-carboxyglutamate. /evidence=ECO:0000250|UniProtKB:P02766; propagated from UniProtKB/Swiss-Prot (P12303.1); gamma-carboxyglutamic-acid site
Phosphoserine. /evidence=ECO:0000250|UniProtKB:P02767; propagated from UniProtKB/Swiss-Prot (P12303.1); phosphorylation site
N-linked (GlcNAc...) asparagine. /evidence=ECO:0000255; propagated from UniProtKB/Swiss-Prot (P12303.1); glycosylation site
propagated from UniProtKB/Swiss-Prot (P12303.1); Region: Thyroid hormone binding. /evidence=ECO:0000250
translation initiation factor IF-2-like, transcript variant X1
translation initiation factor IF-2-like, transcript variant X3
translation initiation factor IF-2-like, transcript variant X2
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 ESTs, 1 Protein, and 57% coverage of the annotated genomic feature by RNAseq alignments
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: inserted 1 base in 1 codon; substituted 2 bases at 2 genomic stop codons; Derived by automated computational analysis using gene prediction method: Gnomon.
transfer RNA serine (anticodon GGA); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
COORDINATES: nucleotide motif:Rfam:12.0:RF00003
carbohydrate sulfotransferase 9, transcript variant X1
carbohydrate sulfotransferase 9, transcript variant X2
carbohydrate sulfotransferase 9 isoform X1
carbohydrate sulfotransferase 9 isoform X2
aquaporin 4; Derived by automated computational analysis using gene prediction method: BestRefSeq,Gnomon.
similar to RNA sequence, mRNA (same species):RefSeq:NM_001009279.1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
potassium channel tetramerization domain containing 1, transcript variant X3
BTB/POZ domain-containing protein KCTD1 isoform X3
potassium channel tetramerization domain containing 1, transcript variant X4
potassium channel tetramerization domain containing 1, transcript variant X1
potassium channel tetramerization domain containing 1, transcript variant X2
BTB/POZ domain-containing protein KCTD1 isoform X1
BTB/POZ domain-containing protein KCTD1 isoform X2
potassium channel tetramerization domain containing 1, transcript variant X5
BTB/POZ domain-containing protein KCTD1 isoform X4
TATA-box binding protein associated factor 4b, transcript variant X1
TATA-box binding protein associated factor 4b, transcript variant X4
TATA-box binding protein associated factor 4b, transcript variant X3
transcription initiation factor TFIID subunit 4B isoform X1
transcription initiation factor TFIID subunit 4B isoform X3
TATA-box binding protein associated factor 4b, transcript variant X2
transcription initiation factor TFIID subunit 4B isoform X2
proteasome 20S subunit alpha 8, transcript variant X2
proteasome 20S subunit alpha 8, transcript variant X1
proteasome 20S subunit alpha 8, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments
proteasome 20S subunit alpha 8, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 97% coverage of the annotated genomic feature by RNAseq alignments
proteasome subunit alpha-type 8 isoform X2
proteasome subunit alpha-type 8 isoform X1
proteasome subunit alpha-type 8 isoform X3
proteasome subunit alpha-type 8 isoform X4
SS18 subunit of BAF chromatin remodeling complex, transcript variant X2
SS18 subunit of BAF chromatin remodeling complex, transcript variant X3
SS18 subunit of BAF chromatin remodeling complex, transcript variant X1
SS18 subunit of BAF chromatin remodeling complex, transcript variant X4
SS18 subunit of BAF chromatin remodeling complex, transcript variant X5
SS18 subunit of BAF chromatin remodeling complex, transcript variant X6
zinc finger protein 521, transcript variant X3
zinc finger protein 521, transcript variant X5
zinc finger protein 521, transcript variant X2
zinc finger protein 521, transcript variant X1
zinc finger protein 521, transcript variant X4
impact RWD domain protein, transcript variant X2
impact RWD domain protein, transcript variant X3
impact RWD domain protein, transcript variant X1
oxysterol binding protein like 1A, transcript variant X1
oxysterol binding protein like 1A, transcript variant X2
oxysterol-binding protein-related protein 1 isoform X1
oxysterol-binding protein-related protein 1 isoform X2
oxysterol binding protein like 1A, transcript variant X3
oxysterol-binding protein-related protein 1 isoform X3
oxysterol binding protein like 1A, transcript variant X6
oxysterol binding protein like 1A, transcript variant X4
oxysterol binding protein like 1A, transcript variant X7
oxysterol binding protein like 1A, transcript variant X5
oxysterol-binding protein-related protein 1 isoform X4
calcium binding tyrosine phosphorylation regulated, transcript variant X4
calcium binding tyrosine phosphorylation regulated, transcript variant X8
calcium binding tyrosine phosphorylation regulated, transcript variant X6
calcium binding tyrosine phosphorylation regulated, transcript variant X5
calcium-binding tyrosine phosphorylation-regulated protein isoform X2
calcium-binding tyrosine phosphorylation-regulated protein isoform X4
calcium binding tyrosine phosphorylation regulated, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
calcium binding tyrosine phosphorylation regulated, transcript variant X9
calcium binding tyrosine phosphorylation regulated, transcript variant X1
calcium binding tyrosine phosphorylation regulated, transcript variant X2
calcium binding tyrosine phosphorylation regulated, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
calcium-binding tyrosine phosphorylation-regulated protein isoform X1
calcium-binding tyrosine phosphorylation-regulated protein isoform X3
laminin subunit alpha 3, transcript variant X1
laminin subunit alpha 3, transcript variant X3
laminin subunit alpha 3, transcript variant X4
laminin subunit alpha 3, transcript variant X2
transfer RNA glycine (anticodon UCC); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 27% coverage of the annotated genomic feature by RNAseq alignments
ankyrin repeat domain 29, transcript variant X3
ankyrin repeat domain 29, transcript variant X4
ankyrin repeat domain-containing protein 29 isoform X3
ankyrin repeat domain-containing protein 29 isoform X4
ankyrin repeat domain 29, transcript variant X7
ankyrin repeat domain 29, transcript variant X8
ankyrin repeat domain 29, transcript variant X1
ankyrin repeat domain 29, transcript variant X2
ankyrin repeat domain 29, transcript variant X5
ankyrin repeat domain 29, transcript variant X6
ankyrin repeat domain-containing protein 29 isoform X1
ankyrin repeat domain-containing protein 29 isoform X2
ankyrin repeat domain-containing protein 29 isoform X5
ankyrin repeat domain-containing protein 29 isoform X6
ankyrin repeat domain-containing protein 29 isoform X7
ankyrin repeat domain-containing protein 29 isoform X8
NPC intracellular cholesterol transporter 1, transcript variant X1
NPC intracellular cholesterol transporter 1 isoform X1
NPC intracellular cholesterol transporter 1, transcript variant X2
NPC intracellular cholesterol transporter 1 isoform X2
LOW QUALITY PROTEIN: regulator of MON1-CCZ1 complex-like
NPC intracellular cholesterol transporter 1-like
regulator of MON1-CCZ1, transcript variant X1
regulator of MON1-CCZ1, transcript variant X2
regulator of MON1-CCZ1 complex isoform X1
regulator of MON1-CCZ1 complex isoform X2
serine/threonine-protein kinase RIO3 isoform X1
serine/threonine-protein kinase RIO3 isoform X2
transmembrane protein 241, transcript variant X3
transmembrane protein 241, transcript variant X1
transmembrane protein 241, transcript variant X4
transmembrane protein 241, transcript variant X9
transmembrane protein 241, transcript variant X6
transmembrane protein 241, transcript variant X8
transmembrane protein 241, transcript variant X5
transmembrane protein 241, transcript variant X7
transmembrane protein 241, transcript variant X2
transmembrane protein 241, transcript variant X11
transmembrane protein 241, transcript variant X10
RB binding protein 8, endonuclease, transcript variant X2
RB binding protein 8, endonuclease, transcript variant X1
RB binding protein 8, endonuclease, transcript variant X3
uncharacterized LOC121817716, transcript variant X1
uncharacterized LOC121817716, transcript variant X2
transfer RNA arginine (anticodon UCU); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
GATA binding protein 6, transcript variant X3
GATA binding protein 6, transcript variant X1
GATA binding protein 6, transcript variant X2
GATA binding protein 6, transcript variant X4
GATA binding protein 6, transcript variant X6
GATA binding protein 6, transcript variant X5
GATA binding protein 6, transcript variant X7
uncharacterized LOC105604459, transcript variant X3
uncharacterized LOC105604459, transcript variant X2
uncharacterized LOC105604459, transcript variant X1
abhydrolase domain containing 3, phospholipase, transcript variant X2
abhydrolase domain containing 3, phospholipase, transcript variant X1
small nuclear ribonucleoprotein D1 polypeptide, transcript variant X3
small nuclear ribonucleoprotein D1 polypeptide, transcript variant X2
small nuclear ribonucleoprotein D1 polypeptide, transcript variant X1
small nuclear ribonucleoprotein Sm D1 isoform X1
small nuclear ribonucleoprotein Sm D1 isoform X2
establishment of sister chromatid cohesion N-acetyltransferase 1, transcript variant X2
establishment of sister chromatid cohesion N-acetyltransferase 1, transcript variant X1
establishment of sister chromatid cohesion N-acetyltransferase 1, transcript variant X3
GREB1 like retinoic acid receptor coactivator
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 EST, 21 Proteins, and 85% coverage of the annotated genomic feature by RNAseq alignments
Rho associated coiled-coil containing protein kinase 1, transcript variant X1
Rho associated coiled-coil containing protein kinase 1, transcript variant X2
rho-associated protein kinase 1 isoform X1
rho-associated protein kinase 1 isoform X2
ubiquitin carboxyl-terminal hydrolase 14
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 85% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 55% coverage of the annotated genomic feature by RNAseq alignments
thymidylate synthetase, transcript variant X1
thymidylate synthetase, transcript variant X2
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: deleted 1 base in 1 codon
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: deleted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: mitochondrial enolase superfamily member 1
YES proto-oncogene 1, Src family tyrosine kinase, transcript variant X1
YES proto-oncogene 1, Src family tyrosine kinase, transcript variant X2
YES proto-oncogene 1, Src family tyrosine kinase, transcript variant X4
YES proto-oncogene 1, Src family tyrosine kinase, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 42% coverage of the annotated genomic feature by RNAseq alignments
adenylate cyclase activating polypeptide 1; Derived by automated computational analysis using gene prediction method: BestRefSeq.
adenylate cyclase activating polypeptide 1
similar to RNA sequence, mRNA (same species):RefSeq:NM_001009776.1
The RefSeq transcript has 6 substitutions, 2 non-frameshifting indels compared to this genomic sequence; Derived by automated computational analysis using gene prediction method: BestRefSeq.
pituitary adenylate cyclase-activating polypeptide precursor
propagated from UniProtKB/Swiss-Prot (P16613.1); Region: Disordered. /evidence=ECO:0000256|SAM:MobiDB-lite
propagated from UniProtKB/Swiss-Prot (P16613.1); Region: Important for receptor binding. /evidence=ECO:0000250
Leucine amide. /evidence=ECO:0000269|PubMed:2383262; propagated from UniProtKB/Swiss-Prot (P16613.1); amidation site
Lysine amide. /evidence=ECO:0000269|PubMed:2302217; propagated from UniProtKB/Swiss-Prot (P16613.1); amidation site
COORDINATES: nucleotide motif:Rfam:12.0:RF00493
COORDINATES: nucleotide motif:Rfam:12.0:RF00494
methyltransferase 4, N6-adenosine; Derived by automated computational analysis using gene prediction method: BestRefSeq,Gnomon.
methyltransferase 4, N6-adenosine, transcript variant X5
methyltransferase 4, N6-adenosine, transcript variant X4
methyltransferase 4, N6-adenosine, transcript variant X2
N(6)-adenine-specific methyltransferase METTL4 isoform X4
N(6)-adenine-specific methyltransferase METTL4 isoform X3
methyltransferase 4, N6-adenosine, transcript variant X3
methyltransferase 4, N6-adenosine, transcript variant X1
similar to RNA sequence, mRNA (same species):RefSeq:NM_001267877.1
The RefSeq transcript has 7 substitutions compared to this genomic sequence; Derived by automated computational analysis using gene prediction method: BestRefSeq.
N(6)-adenine-specific methyltransferase METTL4 isoform X2
similar to AA sequence (same species):RefSeq:NP_001254806.1
The RefSeq protein has 5 substitutions compared to this genomic sequence; Derived by automated computational analysis using gene prediction method: BestRefSeq.
N(6)-adenine-specific methyltransferase METTL4
N(6)-adenine-specific methyltransferase METTL4 isoform X1
structural maintenance of chromosomes flexible hinge domain containing 1, transcript variant X2
structural maintenance of chromosomes flexible hinge domain containing 1, transcript variant X1
structural maintenance of chromosomes flexible hinge domain-containing protein 1 isoform X2
structural maintenance of chromosomes flexible hinge domain-containing protein 1 isoform X1
structural maintenance of chromosomes flexible hinge domain containing 1, transcript variant X3
structural maintenance of chromosomes flexible hinge domain containing 1, transcript variant X4
structural maintenance of chromosomes flexible hinge domain-containing protein 1 isoform X3
elastin microfibril interfacer 2, transcript variant X1
elastin microfibril interfacer 2, transcript variant X2
phosphatidate phosphatase LPIN2 isoform X3
phosphatidate phosphatase LPIN2 isoform X1
phosphatidate phosphatase LPIN2 isoform X2
phosphatidate phosphatase LPIN2 isoform X4
phosphatidate phosphatase LPIN2 isoform X5
phosphatidate phosphatase LPIN2 isoform X6
myosin regulatory light chain MRCL3; Derived by automated computational analysis using gene prediction method: BestRefSeq,Gnomon.
myosin regulatory light chain MRCL3, transcript variant X1
myosin regulatory light chain MRCL3, transcript variant X2
myosin regulatory light chain MRCL3 isoform X1
similar to RNA sequence, mRNA (same species):RefSeq:NM_001145182.1
The RefSeq transcript has 6 substitutions compared to this genomic sequence; Derived by automated computational analysis using gene prediction method: BestRefSeq.
myosin regulatory light chain MRCL3 isoform X2
similar to AA sequence (same species):RefSeq:NP_001138654.1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 41 samples with support for all annotated introns
TGFB induced factor homeobox 1, transcript variant X2
TGFB induced factor homeobox 1, transcript variant X1
TGFB induced factor homeobox 1, transcript variant X3
DLG associated protein 1, transcript variant X3
DLG associated protein 1, transcript variant X2
DLG associated protein 1, transcript variant X1
DLG associated protein 1, transcript variant X6
DLG associated protein 1, transcript variant X4
DLG associated protein 1, transcript variant X8
DLG associated protein 1, transcript variant X5
DLG associated protein 1, transcript variant X7
disks large-associated protein 1 isoform X3
disks large-associated protein 1 isoform X2
disks large-associated protein 1 isoform X1
disks large-associated protein 1 isoform X6
disks large-associated protein 1 isoform X4
disks large-associated protein 1 isoform X8
disks large-associated protein 1 isoform X5
disks large-associated protein 1 isoform X7
DLG associated protein 1, transcript variant X9
disks large-associated protein 1 isoform X9
zinc finger and BTB domain containing 14, transcript variant X5
zinc finger and BTB domain containing 14, transcript variant X3
zinc finger and BTB domain containing 14, transcript variant X2
zinc finger and BTB domain containing 14, transcript variant X6
zinc finger and BTB domain containing 14, transcript variant X1
zinc finger and BTB domain containing 14, transcript variant X4
zinc finger and BTB domain-containing protein 14
erythrocyte membrane protein band 4.1 like 3, transcript variant X11
erythrocyte membrane protein band 4.1 like 3, transcript variant X10
erythrocyte membrane protein band 4.1 like 3, transcript variant X6
erythrocyte membrane protein band 4.1 like 3, transcript variant X8
erythrocyte membrane protein band 4.1 like 3, transcript variant X4
erythrocyte membrane protein band 4.1 like 3, transcript variant X2
erythrocyte membrane protein band 4.1 like 3, transcript variant X1
erythrocyte membrane protein band 4.1 like 3, transcript variant X3
erythrocyte membrane protein band 4.1 like 3, transcript variant X5
erythrocyte membrane protein band 4.1 like 3, transcript variant X7
erythrocyte membrane protein band 4.1 like 3, transcript variant X15
erythrocyte membrane protein band 4.1 like 3, transcript variant X12
erythrocyte membrane protein band 4.1 like 3, transcript variant X13
erythrocyte membrane protein band 4.1 like 3, transcript variant X17
erythrocyte membrane protein band 4.1 like 3, transcript variant X20
erythrocyte membrane protein band 4.1 like 3, transcript variant X16
erythrocyte membrane protein band 4.1 like 3, transcript variant X14
erythrocyte membrane protein band 4.1 like 3, transcript variant X18
erythrocyte membrane protein band 4.1 like 3, transcript variant X21
erythrocyte membrane protein band 4.1 like 3, transcript variant X19
erythrocyte membrane protein band 4.1 like 3, transcript variant X9
uncharacterized LOC105604471, transcript variant X1
uncharacterized LOC105604471, transcript variant X2
uncharacterized LOC105604472, transcript variant X2
uncharacterized LOC105604472, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 long SRA reads, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
Rho GTPase activating protein 28, transcript variant X3
Rho GTPase activating protein 28, transcript variant X4
Rho GTPase activating protein 28, transcript variant X1
Rho GTPase activating protein 28, transcript variant X2
Rho GTPase activating protein 28, transcript variant X6
rho GTPase-activating protein 28 isoform X1
rho GTPase-activating protein 28 isoform X2
rho GTPase-activating protein 28 isoform X5
rho GTPase-activating protein 28 isoform X3
Rho GTPase activating protein 28, transcript variant X7
Rho GTPase activating protein 28, transcript variant X5
rho GTPase-activating protein 28 isoform X4
rho GTPase-activating protein 28 isoform X6
laminin subunit alpha 1, transcript variant X2
laminin subunit alpha 1, transcript variant X1
leucine-rich repeat-containing protein 30
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 7 bases in 5 codons; deleted 2 bases in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 76% coverage of the annotated genomic feature by RNAseq alignments
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: inserted 7 bases in 5 codons; deleted 2 bases in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: leucine-rich repeat-containing protein 30
protein tyrosine phosphatase receptor type M, transcript variant X1
protein tyrosine phosphatase receptor type M, transcript variant X4
protein tyrosine phosphatase receptor type M, transcript variant X2
protein tyrosine phosphatase receptor type M, transcript variant X5
protein tyrosine phosphatase receptor type M, transcript variant X3
protein tyrosine phosphatase receptor type M, transcript variant X7
protein tyrosine phosphatase receptor type M, transcript variant X6
protein tyrosine phosphatase receptor type M, transcript variant X9
protein tyrosine phosphatase receptor type M, transcript variant X8
protein tyrosine phosphatase receptor type M, transcript variant X10
receptor-type tyrosine-protein phosphatase mu isoform X1
receptor-type tyrosine-protein phosphatase mu isoform X4
receptor-type tyrosine-protein phosphatase mu isoform X2
receptor-type tyrosine-protein phosphatase mu isoform X5
receptor-type tyrosine-protein phosphatase mu isoform X3
receptor-type tyrosine-protein phosphatase mu isoform X7
receptor-type tyrosine-protein phosphatase mu isoform X6
receptor-type tyrosine-protein phosphatase mu isoform X9
receptor-type tyrosine-protein phosphatase mu isoform X8
receptor-type tyrosine-protein phosphatase mu isoform X10
protein tyrosine phosphatase receptor type M, transcript variant X11
receptor-type tyrosine-protein phosphatase mu isoform X11
microtubule crosslinking factor 1, transcript variant X1
microtubule crosslinking factor 1, transcript variant X4
microtubule crosslinking factor 1, transcript variant X6
microtubule crosslinking factor 1, transcript variant X2
microtubule crosslinking factor 1, transcript variant X3
microtubule crosslinking factor 1, transcript variant X5
microtubule cross-linking factor 1 isoform X1
microtubule cross-linking factor 1 isoform X4
microtubule cross-linking factor 1 isoform X6
microtubule cross-linking factor 1 isoform X2
microtubule cross-linking factor 1 isoform X3
microtubule cross-linking factor 1 isoform X5
microtubule crosslinking factor 1, transcript variant X7
microtubule cross-linking factor 1 isoform X7
uncharacterized LOC121817758, transcript variant X2
uncharacterized LOC121817758, transcript variant X1
uncharacterized LOC121817758, transcript variant X3
NADH:ubiquinone oxidoreductase core subunit V2, transcript variant X2
NADH:ubiquinone oxidoreductase core subunit V2, transcript variant X1
NADH dehydrogenase [ubiquinone] flavoprotein 2, mitochondrial
ankyrin repeat domain 12, transcript variant X1
ankyrin repeat domain 12, transcript variant X3
ankyrin repeat domain 12, transcript variant X4
ankyrin repeat domain 12, transcript variant X2
ankyrin repeat domain-containing protein 12 isoform X1
ankyrin repeat domain-containing protein 12 isoform X2
ankyrin repeat domain-containing protein 12 isoform X3
twisted gastrulation BMP signaling modulator 1
ralA binding protein 1, transcript variant X2
ralA binding protein 1, transcript variant X1
ralA binding protein 1, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 long SRA read, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
protein phosphatase 4 regulatory subunit 1, transcript variant X5
protein phosphatase 4 regulatory subunit 1, transcript variant X4
protein phosphatase 4 regulatory subunit 1, transcript variant X3
protein phosphatase 4 regulatory subunit 1, transcript variant X2
protein phosphatase 4 regulatory subunit 1, transcript variant X1
protein phosphatase 4 regulatory subunit 1, transcript variant X6
serine/threonine-protein phosphatase 4 regulatory subunit 1 isoform X5
serine/threonine-protein phosphatase 4 regulatory subunit 1 isoform X4
serine/threonine-protein phosphatase 4 regulatory subunit 1 isoform X3
serine/threonine-protein phosphatase 4 regulatory subunit 1 isoform X2
serine/threonine-protein phosphatase 4 regulatory subunit 1 isoform X1
serine/threonine-protein phosphatase 4 regulatory subunit 1 isoform X6
RAB31, member RAS oncogene family, transcript variant X1
RAB31, member RAS oncogene family, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
VAMP associated protein A, transcript variant X1
VAMP associated protein A, transcript variant X2
vesicle-associated membrane protein-associated protein A isoform X1
vesicle-associated membrane protein-associated protein A isoform X2
uncharacterized LOC114110457, transcript variant X2
uncharacterized LOC114110457, transcript variant X1
APC down-regulated 1, transcript variant X2
APC down-regulated 1, transcript variant X1
uncharacterized LOC105604488, transcript variant X2
uncharacterized LOC105604488, transcript variant X1
NSF attachment protein gamma, transcript variant X4
NSF attachment protein gamma, transcript variant X1
NSF attachment protein gamma, transcript variant X3
NSF attachment protein gamma, transcript variant X2
gamma-soluble NSF attachment protein isoform X1
gamma-soluble NSF attachment protein isoform X2
gamma-soluble NSF attachment protein isoform X3
gamma-soluble NSF attachment protein isoform X4
piezo type mechanosensitive ion channel component 2, transcript variant X2
piezo type mechanosensitive ion channel component 2, transcript variant X1
piezo type mechanosensitive ion channel component 2, transcript variant X4
piezo-type mechanosensitive ion channel component 2 isoform X2
piezo-type mechanosensitive ion channel component 2 isoform X4
piezo-type mechanosensitive ion channel component 2 isoform X1
piezo type mechanosensitive ion channel component 2, transcript variant X3
piezo-type mechanosensitive ion channel component 2 isoform X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 long SRA reads, and 96% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
guanine nucleotide-binding protein G(olf) subunit alpha
metallophosphoesterase 1, transcript variant X7
metallophosphoesterase 1, transcript variant X2
metallophosphoesterase 1, transcript variant X9
metallophosphoesterase 1, transcript variant X6
metallophosphoesterase 1, transcript variant X8
metallophosphoesterase 1, transcript variant X4
metallophosphoesterase 1, transcript variant X3
metallophosphoesterase 1, transcript variant X1
metallophosphoesterase 1, transcript variant X5
metallophosphoesterase 1, transcript variant X10
inositol monophosphatase 2, transcript variant X1
inositol monophosphatase 2, transcript variant X2
cell death inducing DFFA like effector a, transcript variant X2
cell death inducing DFFA like effector a, transcript variant X1
cell death inducing DFFA like effector a, transcript variant X3
AFG3 like matrix AAA peptidase subunit 2, transcript variant X2
AFG3 like matrix AAA peptidase subunit 2, transcript variant X1
AFG3 like matrix AAA peptidase subunit 2, transcript variant X4
AFG3 like matrix AAA peptidase subunit 2, transcript variant X3
PRELI domain containing 3A, transcript variant X9
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
PRELI domain containing protein 3A isoform X4
PRELI domain containing 3A, transcript variant X2
PRELI domain containing 3A, transcript variant X4
PRELI domain containing 3A, transcript variant X3
PRELI domain containing 3A, transcript variant X5
PRELI domain containing 3A, transcript variant X7
PRELI domain containing 3A, transcript variant X6
PRELI domain containing 3A, transcript variant X8
PRELI domain containing 3A, transcript variant X1
PRELI domain containing 3A, transcript variant X11
PRELI domain containing 3A, transcript variant X10
PRELI domain containing protein 3A isoform X6
PRELI domain containing protein 3A isoform X5
PRELI domain containing protein 3A isoform X3
PRELI domain containing protein 3A isoform X2
PRELI domain containing protein 3A isoform X1
spire type actin nucleation factor 1, transcript variant X7
spire type actin nucleation factor 1, transcript variant X6
spire type actin nucleation factor 1, transcript variant X4
spire type actin nucleation factor 1, transcript variant X3
spire type actin nucleation factor 1, transcript variant X2
spire type actin nucleation factor 1, transcript variant X1
spire type actin nucleation factor 1, transcript variant X5
centrosomal protein 76, transcript variant X2
centrosomal protein 76, transcript variant X1
centrosomal protein of 76 kDa isoform X2
centrosomal protein of 76 kDa isoform X1
proteasome assembly chaperone 2, transcript variant X1
proteasome assembly chaperone 2, transcript variant X2
proteasome assembly chaperone 2 isoform X1
proteasome assembly chaperone 2 isoform X2
small nucleolar RNA SNORA2/SNORA34 family
COORDINATES: nucleotide motif:Rfam:12.0:RF00410
protein tyrosine phosphatase non-receptor type 2, transcript variant X8
protein tyrosine phosphatase non-receptor type 2, transcript variant X7
protein tyrosine phosphatase non-receptor type 2, transcript variant X3
protein tyrosine phosphatase non-receptor type 2, transcript variant X2
protein tyrosine phosphatase non-receptor type 2, transcript variant X5
protein tyrosine phosphatase non-receptor type 2, transcript variant X6
protein tyrosine phosphatase non-receptor type 2, transcript variant X4
tyrosine-protein phosphatase non-receptor type 2 isoform X4
tyrosine-protein phosphatase non-receptor type 2 isoform X5
tyrosine-protein phosphatase non-receptor type 2 isoform X2
tyrosine-protein phosphatase non-receptor type 2 isoform X3
protein tyrosine phosphatase non-receptor type 2, transcript variant X1
tyrosine-protein phosphatase non-receptor type 2 isoform X1
SEH1 like nucleoporin, transcript variant X3
SEH1 like nucleoporin, transcript variant X1
SEH1 like nucleoporin, transcript variant X2
SEH1 like nucleoporin, transcript variant X4
centrosomal protein 192, transcript variant X1
centrosomal protein 192, transcript variant X2
centrosomal protein 192, transcript variant X3
centrosomal protein of 192 kDa isoform X1
centrosomal protein of 192 kDa isoform X2
centrosomal protein of 192 kDa isoform X3
low density lipoprotein receptor class A domain containing 4
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 1 base in 1 codon
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: inserted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: low-density lipoprotein receptor class A domain-containing protein 4
family with sequence similarity 210 member A, transcript variant X1
family with sequence similarity 210 member A, transcript variant X2
family with sequence similarity 210 member A, transcript variant X3
family with sequence similarity 210 member A, transcript variant X4
RNA guanine-7 methyltransferase, transcript variant X1
RNA guanine-7 methyltransferase, transcript variant X2
melanocortin 5 receptor; Derived by automated computational analysis using gene prediction method: BestRefSeq,Gnomon.
melanocortin 5 receptor, transcript variant X1
similar to RNA sequence, mRNA (same species):RefSeq:NM_001078656.1
The RefSeq transcript has 3 substitutions compared to this genomic sequence; Derived by automated computational analysis using gene prediction method: BestRefSeq.
similar to AA sequence (same species):RefSeq:NP_001072124.1
N-linked (GlcNAc...) asparagine. /evidence=ECO:0000255; propagated from UniProtKB/Swiss-Prot (P41983.1); glycosylation site
propagated from UniProtKB/Swiss-Prot (P41983.1); transmembrane region
melanocortin 2 receptor; Derived by automated computational analysis using gene prediction method: BestRefSeq,Gnomon.
melanocortin 2 receptor, transcript variant X1
adrenocorticotropic hormone receptor isoform X1
similar to RNA sequence, mRNA (same species):RefSeq:NM_001009442.1
The RefSeq transcript has 4 substitutions compared to this genomic sequence; Derived by automated computational analysis using gene prediction method: BestRefSeq.
similar to AA sequence (same species):RefSeq:NP_001009442.1
The RefSeq protein has 2 substitutions compared to this genomic sequence; stop codon completed by the addition of 3' A residues to the mRNA; Derived by automated computational analysis using gene prediction method: BestRefSeq.
N-linked (GlcNAc...) asparagine. /evidence=ECO:0000255; propagated from UniProtKB/Swiss-Prot (Q9TU77.1); glycosylation site
propagated from UniProtKB/Swiss-Prot (Q9TU77.1); transmembrane region
heterogeneous nuclear ribonucleoproteins A2/B1-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 58% coverage of the annotated genomic feature by RNAseq alignments
transfer RNA tyrosine (anticodon AUA); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
solute carrier family 14 member 2, transcript variant X2
solute carrier family 14 member 2, transcript variant X1
solute carrier family 14 member 2, transcript variant X3
uncharacterized LOC105610529, transcript variant X2
uncharacterized LOC105610529, transcript variant X3
uncharacterized LOC105610529, transcript variant X1
uncharacterized LOC105610529, transcript variant X4
solute carrier family 14 member 2, transcript variant X4
solute carrier family 14 member 1 (Kidd blood group); Derived by automated computational analysis using gene prediction method: BestRefSeq,Gnomon.
solute carrier family 14 member 1 (Kidd blood group), transcript variant X1
solute carrier family 14 member 1 (Kidd blood group), transcript variant X2
solute carrier family 14 member 1 (Kidd blood group), transcript variant X3
solute carrier family 14 member 1 (Kidd blood group), transcript variant X4
solute carrier family 14 member 1 (Kidd blood group)
propagated from UniProtKB/Swiss-Prot (C5MK33.1); Region: Disordered. /evidence=ECO:0000256|SAM:MobiDB-lite
propagated from UniProtKB/Swiss-Prot (C5MK33.1); transmembrane region
N-linked (GlcNAc...) asparagine. /evidence=ECO:0000255; propagated from UniProtKB/Swiss-Prot (C5MK33.1); glycosylation site
Important for channel permeability. /evidence=ECO:0000250; propagated from UniProtKB/Swiss-Prot (C5MK33.1); other site
ectopic P-granules autophagy protein 5 homolog, transcript variant X3
ectopic P-granules autophagy protein 5 homolog, transcript variant X2
ectopic P-granules autophagy protein 5 homolog, transcript variant X1
ectopic P granules protein 5 homolog isoform X3
ectopic P granules protein 5 homolog isoform X2
ectopic P granules protein 5 homolog isoform X1
proline-serine-threonine phosphatase interacting protein 2, transcript variant X2
proline-serine-threonine phosphatase interacting protein 2, transcript variant X1
proline-serine-threonine phosphatase-interacting protein 2 isoform X2
proline-serine-threonine phosphatase-interacting protein 2 isoform X1
ATP synthase subunit alpha, mitochondrial
HAUS augmin like complex subunit 1, transcript variant X1
HAUS augmin like complex subunit 1, transcript variant X2
HAUS augmin like complex subunit 1, transcript variant X3
HAUS augmin-like complex subunit 1 isoform X1
HAUS augmin-like complex subunit 1 isoform X2
HAUS augmin-like complex subunit 1 isoform X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
chromosome 23 C18orf25 homolog, transcript variant X2
chromosome 23 C18orf25 homolog, transcript variant X1
chromosome 23 C18orf25 homolog, transcript variant X4
chromosome 23 C18orf25 homolog, transcript variant X3
uncharacterized protein C18orf25 homolog isoform X1
uncharacterized protein C18orf25 homolog isoform X3
uncharacterized protein C18orf25 homolog isoform X2
lipoxygenase homology PLAT domains 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 long SRA read, 3 Proteins, and 49% coverage of the annotated genomic feature by RNAseq alignments
lipoxygenase homology PLAT domains 1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 long SRA read, 5 Proteins, and 47% coverage of the annotated genomic feature by RNAseq alignments
lipoxygenase homology domain-containing protein 1 isoform X2
lipoxygenase homology domain-containing protein 1 isoform X1
ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 5, transcript variant X4
ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 5, transcript variant X3
ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 5, transcript variant X2
ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 5, transcript variant X1
alpha-2,8-sialyltransferase 8E isoform X4
alpha-2,8-sialyltransferase 8E isoform X3
alpha-2,8-sialyltransferase 8E isoform X2
alpha-2,8-sialyltransferase 8E isoform X1
protein inhibitor of activated STAT 2, transcript variant X9
protein inhibitor of activated STAT 2, transcript variant X13
protein inhibitor of activated STAT 2, transcript variant X8
protein inhibitor of activated STAT 2, transcript variant X2
protein inhibitor of activated STAT 2, transcript variant X1
protein inhibitor of activated STAT 2, transcript variant X3
protein inhibitor of activated STAT 2, transcript variant X6
protein inhibitor of activated STAT 2, transcript variant X4
protein inhibitor of activated STAT 2, transcript variant X5
protein inhibitor of activated STAT 2, transcript variant X7
protein inhibitor of activated STAT 2, transcript variant X12
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 EST, 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 80 samples with support for all annotated introns
protein inhibitor of activated STAT 2, transcript variant X14
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 EST, 7 Proteins, and 97% coverage of the annotated genomic feature by RNAseq alignments
protein inhibitor of activated STAT 2, transcript variant X11
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 EST, 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 105 samples with support for all annotated introns
protein inhibitor of activated STAT 2, transcript variant X10
katanin p60 ATPase-containing subunit A-like 2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 53% coverage of the annotated genomic feature by RNAseq alignments
haloacid dehalogenase like hydrolase domain containing 2, transcript variant X1
haloacid dehalogenase like hydrolase domain containing 2, transcript variant X2
haloacid dehalogenase-like hydrolase domain-containing protein 2
immediate early response 3 interacting protein 1
immediate early response 3-interacting protein 1
SKI family transcriptional corepressor 2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 73% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
SMAD family member 2, transcript variant X4
SMAD family member 2, transcript variant X2
SMAD family member 2, transcript variant X3
SMAD family member 2, transcript variant X1
mothers against decapentaplegic homolog 2 isoform X2
mothers against decapentaplegic homolog 2 isoform X1
uncharacterized LOC105604507, transcript variant X2
uncharacterized LOC105604507, transcript variant X1
zinc finger and BTB domain containing 7C, transcript variant X3
zinc finger and BTB domain containing 7C, transcript variant X2
zinc finger and BTB domain containing 7C, transcript variant X1
zinc finger and BTB domain containing 7C, transcript variant X4
zinc finger and BTB domain-containing protein 7C isoform X2
zinc finger and BTB domain-containing protein 7C isoform X1
zinc finger and BTB domain-containing protein 7C isoform X3
uncharacterized LOC114110465, transcript variant X1
uncharacterized LOC114110465, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins
cap binding complex dependent translation initiation factor, transcript variant X1
cap binding complex dependent translation initiation factor, transcript variant X5
cap binding complex dependent translation initiation factor, transcript variant X2
cap binding complex dependent translation initiation factor, transcript variant X4
cap binding complex dependent translation initiation factor, transcript variant X3
CBP80/20-dependent translation initiation factor isoform X1
CBP80/20-dependent translation initiation factor isoform X2
SMAD family member 7, transcript variant X2
SMAD family member 7, transcript variant X1
mothers against decapentaplegic homolog 7 isoform X1
mothers against decapentaplegic homolog 7 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 16 Proteins, and 89% coverage of the annotated genomic feature by RNAseq alignments
mitochondrial import inner membrane translocase subunit TIM14-like
60S ribosomal protein L17, transcript variant X4
chromosome 23 C18orf32 homolog, transcript variant X1
chromosome 23 C18orf32 homolog, transcript variant X3
chromosome 23 C18orf32 homolog, transcript variant X2
60S ribosomal protein L17, transcript variant X3
60S ribosomal protein L17, transcript variant X1
60S ribosomal protein L17, transcript variant X2
COORDINATES: nucleotide motif:Rfam:12.0:RF00151
lipase G, endothelial type, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 33 samples with support for all annotated introns
lipase G, endothelial type, transcript variant X1
lipase G, endothelial type, transcript variant X3
acetyl-CoA acyltransferase 2, transcript variant X2
acetyl-CoA acyltransferase 2, transcript variant X1
3-ketoacyl-CoA thiolase, mitochondrial isoform X2
3-ketoacyl-CoA thiolase, mitochondrial isoform X1
COORDINATES: nucleotide motif:Rfam:12.0:RF00492
COORDINATES: nucleotide motif:Rfam:12.0:RF00283
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 54 Proteins
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 86% coverage of the annotated genomic feature by RNAseq alignments
methyl-CpG binding domain protein 1, transcript variant X12
methyl-CpG binding domain protein 1, transcript variant X7
methyl-CpG binding domain protein 1, transcript variant X11
methyl-CpG binding domain protein 1, transcript variant X9
methyl-CpG binding domain protein 1, transcript variant X6
methyl-CpG binding domain protein 1, transcript variant X5
methyl-CpG binding domain protein 1, transcript variant X4
methyl-CpG binding domain protein 1, transcript variant X2
methyl-CpG binding domain protein 1, transcript variant X13
methyl-CpG binding domain protein 1, transcript variant X10
methyl-CpG binding domain protein 1, transcript variant X3
methyl-CpG binding domain protein 1, transcript variant X8
methyl-CpG binding domain protein 1, transcript variant X1
methyl-CpG-binding domain protein 1 isoform X12
methyl-CpG-binding domain protein 1 isoform X7
methyl-CpG-binding domain protein 1 isoform X11
methyl-CpG-binding domain protein 1 isoform X9
methyl-CpG-binding domain protein 1 isoform X6
methyl-CpG-binding domain protein 1 isoform X5
methyl-CpG-binding domain protein 1 isoform X4
methyl-CpG-binding domain protein 1 isoform X2
methyl-CpG-binding domain protein 1 isoform X13
methyl-CpG-binding domain protein 1 isoform X10
methyl-CpG-binding domain protein 1 isoform X3
methyl-CpG-binding domain protein 1 isoform X8
methyl-CpG-binding domain protein 1 isoform X1
methyl-CpG binding domain protein 1, transcript variant X14
methyl-CpG-binding domain protein 1 isoform X14
methyl-CpG binding domain protein 1, transcript variant X15
methyl-CpG-binding domain protein 1 isoform X15
methyl-CpG binding domain protein 1, transcript variant X17
methyl-CpG binding domain protein 1, transcript variant X18
methyl-CpG binding domain protein 1, transcript variant X16
methyl-CpG-binding domain protein 1 isoform X16
methyl-CpG binding domain protein 1, transcript variant X31
methyl-CpG binding domain protein 1, transcript variant X24
methyl-CpG-binding domain protein 1 isoform X29
methyl-CpG-binding domain protein 1 isoform X22
methyl-CpG binding domain protein 1, transcript variant X38
methyl-CpG binding domain protein 1, transcript variant X41
methyl-CpG binding domain protein 1, transcript variant X37
methyl-CpG binding domain protein 1, transcript variant X35
methyl-CpG binding domain protein 1, transcript variant X42
methyl-CpG binding domain protein 1, transcript variant X33
methyl-CpG binding domain protein 1, transcript variant X40
methyl-CpG binding domain protein 1, transcript variant X25
methyl-CpG binding domain protein 1, transcript variant X36
methyl-CpG binding domain protein 1, transcript variant X26
methyl-CpG binding domain protein 1, transcript variant X22
methyl-CpG binding domain protein 1, transcript variant X34
methyl-CpG binding domain protein 1, transcript variant X29
methyl-CpG binding domain protein 1, transcript variant X30
methyl-CpG binding domain protein 1, transcript variant X27
methyl-CpG binding domain protein 1, transcript variant X39
methyl-CpG binding domain protein 1, transcript variant X23
methyl-CpG binding domain protein 1, transcript variant X20
methyl-CpG binding domain protein 1, transcript variant X32
methyl-CpG binding domain protein 1, transcript variant X21
methyl-CpG binding domain protein 1, transcript variant X19
methyl-CpG binding domain protein 1, transcript variant X28
methyl-CpG-binding domain protein 1 isoform X36
methyl-CpG-binding domain protein 1 isoform X31
methyl-CpG-binding domain protein 1 isoform X23
methyl-CpG-binding domain protein 1 isoform X20
methyl-CpG-binding domain protein 1 isoform X25
methyl-CpG-binding domain protein 1 isoform X18
methyl-CpG-binding domain protein 1 isoform X17
methyl-CpG-binding domain protein 1 isoform X40
methyl-CpG-binding domain protein 1 isoform X24
methyl-CpG-binding domain protein 1 isoform X28
methyl-CpG-binding domain protein 1 isoform X21
methyl-CpG-binding domain protein 1 isoform X19
methyl-CpG-binding domain protein 1 isoform X39
methyl-CpG-binding domain protein 1 isoform X35
methyl-CpG-binding domain protein 1 isoform X33
methyl-CpG-binding domain protein 1 isoform X38
methyl-CpG-binding domain protein 1 isoform X34
methyl-CpG-binding domain protein 1 isoform X32
methyl-CpG-binding domain protein 1 isoform X27
methyl-CpG-binding domain protein 1 isoform X37
methyl-CpG-binding domain protein 1 isoform X30
methyl-CpG-binding domain protein 1 isoform X26
CXXC finger protein 1, transcript variant X4
CXXC finger protein 1, transcript variant X2
CXXC finger protein 1, transcript variant X3
CXXC finger protein 1, transcript variant X1
CXXC-type zinc finger protein 1 isoform X4
CXXC-type zinc finger protein 1 isoform X2
CXXC-type zinc finger protein 1 isoform X3
CXXC-type zinc finger protein 1 isoform X1
spindle and kinetochore associated complex subunit 1, transcript variant X1
spindle and kinetochore associated complex subunit 1, transcript variant X2
spindle and kinetochore-associated protein 1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 70% coverage of the annotated genomic feature by RNAseq alignments
NAD-dependent malic enzyme, mitochondrial isoform X1
NAD-dependent malic enzyme, mitochondrial isoform X2
elaC ribonuclease Z 1, transcript variant X2
elaC ribonuclease Z 1, transcript variant X3
elaC ribonuclease Z 1, transcript variant X1
SMAD family member 4; Derived by automated computational analysis using gene prediction method: BestRefSeq,Gnomon.
SMAD family member 4, transcript variant X1
SMAD family member 4, transcript variant X3
SMAD family member 4, transcript variant X2
similar to RNA sequence, mRNA (same species):RefSeq:NM_001267886.1
mothers against decapentaplegic homolog 4 isoform X1
mothers against decapentaplegic homolog 4
RNA-binding E3 ubiquitin-protein ligase MEX3C
DCC netrin 1 receptor, transcript variant X1
DCC netrin 1 receptor, transcript variant X2
cilia- and flagella-associated protein 36-like
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 2 bases in 2 codons; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 87% coverage of the annotated genomic feature by RNAseq alignments
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: inserted 2 bases in 2 codons; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: cilia- and flagella-associated protein 36-like
methyl-CpG binding domain protein 2, transcript variant X2
methyl-CpG binding domain protein 2, transcript variant X1
methyl-CpG-binding domain protein 2 isoform X2
methyl-CpG-binding domain protein 2 isoform X1
DNA polymerase iota, transcript variant X8
DNA polymerase iota, transcript variant X6
DNA polymerase iota, transcript variant X9
DNA polymerase iota, transcript variant X7
DNA polymerase iota, transcript variant X1
DNA polymerase iota, transcript variant X2
DNA polymerase iota, transcript variant X3
DNA polymerase iota, transcript variant X4
DNA polymerase iota, transcript variant X5
StAR related lipid transfer domain containing 6, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 long SRA read, 1 Protein, and 92% coverage of the annotated genomic feature by RNAseq alignments
StAR related lipid transfer domain containing 6, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 40 samples with support for all annotated introns
StAR related lipid transfer domain containing 6, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
chromosome 23 C18orf54 homolog, transcript variant X4
chromosome 23 C18orf54 homolog, transcript variant X1
chromosome 23 C18orf54 homolog, transcript variant X5
chromosome 23 C18orf54 homolog, transcript variant X2
chromosome 23 C18orf54 homolog, transcript variant X3
lung adenoma susceptibility protein 2 isoform X2
lung adenoma susceptibility protein 2 isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
RAB27B, member RAS oncogene family, transcript variant X2
RAB27B, member RAS oncogene family, transcript variant X3
RAB27B, member RAS oncogene family, transcript variant X1
coiled-coil domain containing 68, transcript variant X2
coiled-coil domain containing 68, transcript variant X1
coiled-coil domain containing 68, transcript variant X3
coiled-coil domain-containing protein 68 isoform X1
coiled-coil domain containing 68, transcript variant X4
coiled-coil domain containing 68, transcript variant X5
coiled-coil domain-containing protein 68 isoform X3
coiled-coil domain-containing protein 68 isoform X2
transcription factor 4, transcript variant X26
transcription factor 4, transcript variant X40
transcription factor 4, transcript variant X15
transcription factor 4, transcript variant X16
transcription factor 4, transcript variant X29
transcription factor 4, transcript variant X28
transcription factor 4, transcript variant X23
transcription factor 4, transcript variant X19
transcription factor 4, transcript variant X24
transcription factor 4, transcript variant X20
transcription factor 4, transcript variant X21
transcription factor 4, transcript variant X18
transcription factor 4, transcript variant X14
transcription factor 4, transcript variant X17
transcription factor 4, transcript variant X13
transcription factor 4, transcript variant X10
transcription factor 4, transcript variant X7
transcription factor 4, transcript variant X11
transcription factor 4, transcript variant X8
transcription factor 4, transcript variant X9
transcription factor 4, transcript variant X6
transcription factor 4, transcript variant X12
transcription factor 4, transcript variant X5
transcription factor 4, transcript variant X2
transcription factor 4, transcript variant X3
transcription factor 4, transcript variant X4
transcription factor 4, transcript variant X1
transcription factor 4, transcript variant X27
transcription factor 4, transcript variant X25
transcription factor 4, transcript variant X22
transcription factor 4, transcript variant X33
transcription factor 4, transcript variant X32
transcription factor 4, transcript variant X30
transcription factor 4, transcript variant X31
transcription factor 4, transcript variant X34
transcription factor 4, transcript variant X38
transcription factor 4, transcript variant X36
transcription factor 4, transcript variant X37
transcription factor 4, transcript variant X35
transcription factor 4, transcript variant X39
thioredoxin like 1, transcript variant X3
thioredoxin like 1, transcript variant X2
thioredoxin like 1, transcript variant X1
thioredoxin like 1, transcript variant X5
thioredoxin like 1, transcript variant X4
uncharacterized LOC105604543, transcript variant X3
uncharacterized LOC105604543, transcript variant X4
uncharacterized LOC105604543, transcript variant X6
uncharacterized LOC105604543, transcript variant X9
uncharacterized LOC105604543, transcript variant X1
uncharacterized LOC105604543, transcript variant X7
uncharacterized LOC105604543, transcript variant X8
uncharacterized LOC105604543, transcript variant X5
uncharacterized LOC105604543, transcript variant X2
uncharacterized LOC105604543, transcript variant X10
WD repeat domain 7, transcript variant X4
WD repeat domain 7, transcript variant X1
WD repeat domain 7, transcript variant X2
WD repeat domain 7, transcript variant X3
WD repeat domain 7, transcript variant X5
WD repeat-containing protein 7 isoform X4
WD repeat-containing protein 7 isoform X1
WD repeat-containing protein 7 isoform X2
WD repeat-containing protein 7 isoform X3
WD repeat-containing protein 7 isoform X5
ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 3
sia-alpha-2,3-Gal-beta-1,4-GlcNAc-R:alpha 2,8-sialyltransferase
asparaginyl-tRNA synthetase 1, transcript variant X3
asparaginyl-tRNA synthetase 1, transcript variant X2
asparaginyl-tRNA synthetase 1, transcript variant X1
asparagine--tRNA ligase, cytoplasmic isoform X2
asparagine--tRNA ligase, cytoplasmic isoform X1
asparagine--tRNA ligase, cytoplasmic isoform X3
uncharacterized LOC105604550, transcript variant X2
uncharacterized LOC105604550, transcript variant X1
ATPase phospholipid transporting 8B1, transcript variant X2
ATPase phospholipid transporting 8B1, transcript variant X1
NEDD4 like E3 ubiquitin protein ligase, transcript variant X8
NEDD4 like E3 ubiquitin protein ligase, transcript variant X7
NEDD4 like E3 ubiquitin protein ligase, transcript variant X9
NEDD4 like E3 ubiquitin protein ligase, transcript variant X11
E3 ubiquitin-protein ligase NEDD4-like isoform X7
E3 ubiquitin-protein ligase NEDD4-like isoform X9
E3 ubiquitin-protein ligase NEDD4-like isoform X11
E3 ubiquitin-protein ligase NEDD4-like isoform X8
NEDD4 like E3 ubiquitin protein ligase, transcript variant X10
E3 ubiquitin-protein ligase NEDD4-like isoform X10
NEDD4 like E3 ubiquitin protein ligase, transcript variant X12
NEDD4 like E3 ubiquitin protein ligase, transcript variant X1
NEDD4 like E3 ubiquitin protein ligase, transcript variant X2
NEDD4 like E3 ubiquitin protein ligase, transcript variant X3
NEDD4 like E3 ubiquitin protein ligase, transcript variant X4
NEDD4 like E3 ubiquitin protein ligase, transcript variant X5
NEDD4 like E3 ubiquitin protein ligase, transcript variant X6
E3 ubiquitin-protein ligase NEDD4-like isoform X1
E3 ubiquitin-protein ligase NEDD4-like isoform X2
E3 ubiquitin-protein ligase NEDD4-like isoform X3
E3 ubiquitin-protein ligase NEDD4-like isoform X4
E3 ubiquitin-protein ligase NEDD4-like isoform X5
E3 ubiquitin-protein ligase NEDD4-like isoform X6
E3 ubiquitin-protein ligase NEDD4-like isoform X12
uncharacterized LOC121817719, transcript variant X2
uncharacterized LOC121817719, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 64% coverage of the annotated genomic feature by RNAseq alignments
uncharacterized LOC105604560, transcript variant X1
uncharacterized LOC105604560, transcript variant X2
MALT1 paracaspase, transcript variant X1
MALT1 paracaspase, transcript variant X2
mucosa-associated lymphoid tissue lymphoma translocation protein 1 isoform X1
mucosa-associated lymphoid tissue lymphoma translocation protein 1 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 57% coverage of the annotated genomic feature by RNAseq alignments
zinc finger protein 532, transcript variant X7
zinc finger protein 532, transcript variant X1
zinc finger protein 532, transcript variant X2
zinc finger protein 532, transcript variant X4
zinc finger protein 532, transcript variant X8
zinc finger protein 532, transcript variant X3
zinc finger protein 532, transcript variant X6
zinc finger protein 532, transcript variant X5
O-acyltransferase like protein-like, transcript variant X1
O-acyltransferase like protein-like, transcript variant X2
O-acyltransferase like protein-like isoform X1
O-acyltransferase like protein-like isoform X2
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 3 bases in 2 codons; deleted 1 base in 1 codon
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: inserted 3 bases in 2 codons; deleted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: ceramide synthase 5-like
SEC11 homolog C, signal peptidase complex subunit
signal peptidase complex catalytic subunit SEC11C
gastrin releasing peptide; Derived by automated computational analysis using gene prediction method: BestRefSeq.
similar to RNA sequence, mRNA (same species):RefSeq:NM_001009321.1
The RefSeq transcript has 7 substitutions, 1 non-frameshifting indel compared to this genomic sequence; Derived by automated computational analysis using gene prediction method: BestRefSeq.
Methionine amide. /evidence=ECO:0000250|UniProtKB:P63153; propagated from UniProtKB/Swiss-Prot (P47851.1); amidation site
propagated from UniProtKB/Swiss-Prot (P47851.1); Region: Disordered. /evidence=ECO:0000256|SAM:MobiDB-lite
retina and anterior neural fold homeobox
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 74% coverage of the annotated genomic feature by RNAseq alignments
lectin, mannose binding 1, transcript variant X2
lectin, mannose binding 1, transcript variant X3
lectin, mannose binding 1, transcript variant X1
lectin, mannose binding 1, transcript variant X4
lectin, mannose binding 1, transcript variant X5
collagen and calcium binding EGF domains 1, transcript variant X2
collagen and calcium binding EGF domains 1, transcript variant X1
collagen and calcium binding EGF domains 1, transcript variant X3
collagen and calcium-binding EGF domain-containing protein 1 isoform X2
collagen and calcium-binding EGF domain-containing protein 1 isoform X1
collagen and calcium-binding EGF domain-containing protein 1 isoform X3
phorbol-12-myristate-13-acetate-induced protein 1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
melanocortin 4 receptor; Derived by automated computational analysis using gene prediction method: BestRefSeq.
similar to RNA sequence, mRNA (same species):RefSeq:NM_001126370.3
The RefSeq transcript has 11 substitutions, 3 non-frameshifting indels compared to this genomic sequence; Derived by automated computational analysis using gene prediction method: BestRefSeq.
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 30 Proteins, and 48% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 96% coverage of the annotated genomic feature by RNAseq alignments
ring finger protein 152, transcript variant X4
ring finger protein 152, transcript variant X1
ring finger protein 152, transcript variant X5
ring finger protein 152, transcript variant X3
ring finger protein 152, transcript variant X2
phosphatidylinositol glycan anchor biosynthesis class N, transcript variant X1
phosphatidylinositol glycan anchor biosynthesis class N, transcript variant X5
phosphatidylinositol glycan anchor biosynthesis class N, transcript variant X4
phosphatidylinositol glycan anchor biosynthesis class N, transcript variant X2
phosphatidylinositol glycan anchor biosynthesis class N, transcript variant X6
GPI ethanolamine phosphate transferase 1 isoform X4
GPI ethanolamine phosphate transferase 1 isoform X3
GPI ethanolamine phosphate transferase 1 isoform X1
GPI ethanolamine phosphate transferase 1 isoform X5
phosphatidylinositol glycan anchor biosynthesis class N, transcript variant X3
GPI ethanolamine phosphate transferase 1 isoform X2
RAB11 binding and LisH domain, coiled-coil and HEAT repeat containing, transcript variant X2
RAB11 binding and LisH domain, coiled-coil and HEAT repeat containing, transcript variant X4
RAB11 binding and LisH domain, coiled-coil and HEAT repeat containing, transcript variant X1
RAB11 binding and LisH domain, coiled-coil and HEAT repeat containing, transcript variant X3
RAB11 binding and LisH domain, coiled-coil and HEAT repeat containing, transcript variant X5
RAB11 binding and LisH domain, coiled-coil and HEAT repeat containing, transcript variant X6
RAB11 binding and LisH domain, coiled-coil and HEAT repeat containing, transcript variant X7
RAB11 binding and LisH domain, coiled-coil and HEAT repeat containing, transcript variant X8
RAB11 binding and LisH domain, coiled-coil and HEAT repeat containing, transcript variant X9
RAB11 binding and LisH domain, coiled-coil and HEAT repeat containing, transcript variant X10
COORDINATES: nucleotide motif:Rfam:12.0:RF00049
TNF receptor superfamily member 11a, transcript variant X1
TNF receptor superfamily member 11a, transcript variant X2
TNF receptor superfamily member 11a, transcript variant X3
TNF receptor superfamily member 11a, transcript variant X4
tumor necrosis factor receptor superfamily member 11A isoform X1
tumor necrosis factor receptor superfamily member 11A isoform X2
tumor necrosis factor receptor superfamily member 11A isoform X3
tumor necrosis factor receptor superfamily member 11A isoform X4
glutaredoxin-related protein 5, mitochondrial
zinc finger CCHC domain-containing protein 2
PH domain and leucine rich repeat protein phosphatase 1
PH domain leucine-rich repeat-containing protein phosphatase 1
BCL2 apoptosis regulator, transcript variant X2
BCL2 apoptosis regulator, transcript variant X1
3-ketodihydrosphingosine reductase, transcript variant X4
3-ketodihydrosphingosine reductase, transcript variant X5
3-ketodihydrosphingosine reductase, transcript variant X2
3-ketodihydrosphingosine reductase, transcript variant X3
3-ketodihydrosphingosine reductase, transcript variant X1
3-ketodihydrosphingosine reductase isoform X2
3-ketodihydrosphingosine reductase isoform X3
3-ketodihydrosphingosine reductase isoform X1
vacuolar protein sorting-associated protein 4B
serpin family B member 12, transcript variant X1
serpin family B member 12, transcript variant X2
serpin family B member 13, transcript variant X1
serpin family B member 13, transcript variant X2
serpin family B member 13, transcript variant X4
serpin family B member 13, transcript variant X5
serpin family B member 13, transcript variant X3
serpin family B member 7, transcript variant X1
serpin family B member 7, transcript variant X2
plasminogen activator inhibitor 2, transcript variant X3
plasminogen activator inhibitor 2, transcript variant X2
plasminogen activator inhibitor 2, transcript variant X1
plasminogen activator inhibitor 2, transcript variant X4
plasminogen activator inhibitor 2, transcript variant X5
plasminogen activator inhibitor 2 isoform X1
plasminogen activator inhibitor 2 isoform X2